Position in BCRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$141,750
-$41,843 QoQ
Shares Held
14,175
-26.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#229
of 316 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DNB Asset Management AS holds $45,753,224 across 11 Drug Manufacturers - Specialty & Generic names. BCRX ranks #11 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
120,337 | $20,281,597 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
245,245 | $8,308,900 | |
| 3 | ZTS |
Zoetis Inc.
|
101,556 | $7,297,814 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
8,646 | $4,684,662 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
55,147 | $1,911,946 | |
| 6 | ALKS |
Alkermes plc.
|
20,328 | $1,065,187 | |
| 7 | VTRS |
Viatris Inc
|
48,883 | $776,262 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
24,879 | $612,272 |
All Filings in BCRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $141,750 | 14,175 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $183,593 | 19,285 | Shares | Other | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||